Clinical Trial Update: Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics/pharmacodynamics of Telpegfilgrastim injection in non-pregnant women of childbearing potenti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Telpegfilgrastim (telpegfilgrastim)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Preeclampsia | Phase 1 | Status: COMPLETED